U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute announces the availability of funding for implementation of the Role of Microbial Metabolites in Cancer Prevention and Etiology (U01) Grant. The purpose of this grant is to stimulate preclinical and clinical research that will describe the effect of microbially generated metabolites in cancer prevention/progression and the molecular mechanisms underlying these effects: proliferative/apoptotic responses, cytokine production, inflammatory, and immunomodulatory effects locally and/or distant. Contractors should refer to Section VII, Agency Contacts, in the RFP for information regarding each Institute's grants management contact . . .